Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Cocrystal Pharma, Inc. from Q1 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Cocrystal Pharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q1 2019 to Q1 2025.
  • Cocrystal Pharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending March 31, 2025 was $249K, a 33.8% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)

Cocrystal Pharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $249K -$127K -33.8% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $376K +$11K +3.01% Dec 31, 2024 10-K 2025-03-31
Q3 2024 $376K Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $376K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $376K Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $365K Dec 31, 2023 10-K 2024-03-28
Q4 2021 $246K Dec 31, 2021 10-K 2022-03-23
Q1 2020 $183K +$5K +2.81% Mar 31, 2020 10-Q 2020-05-13
Q3 2019 $178K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $178K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $178K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.